{"id":61733,"date":"2025-08-15T13:05:31","date_gmt":"2025-08-15T11:05:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/"},"modified":"2025-08-15T13:05:31","modified_gmt":"2025-08-15T11:05:31","slug":"canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/","title":{"rendered":"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs.<\/i><\/li>\n<li>\n<i>Canopy Growth shareholders with a 16-digit control number can vote online at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Furldefense.com%2Fv3%2F__http%3A%2Fproxyvote.com%2F__%3B%21%21CpR1s-QEqjqWCg%21MY9PRtIWY0PfxnUstKKNl8h7DGuvJ3C5QhPSn3NOWt7BryTU1eBPPHhy9t-XP8739tUQeS29uX6WJirkQlAcMbvtpyI4e5xp%24&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=http%3A%2F%2Fproxyvote.com&amp;index=1&amp;md5=7269d3d4dfaf888b9e2d36ccac81a636\" rel=\"nofollow\" shape=\"rect\">http:\/\/proxyvote.com<\/a>, and by phone at 1-800-474-7493.<\/i><\/li>\n<li>\n<i>For more information, shareholders should contact Canopy Growth\u2019s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory Group, at 1-877-452-7184 (1\u2011416\u2011304\u20110211 for collect calls outside North America) or by email at <a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x61;&#x73;s&#105;&#x73;&#x74;a&#110;&#99;&#x65;&#x40;l&#97;&#x75;&#x72;e&#108;&#104;&#x69;&#x6c;l&#46;&#x63;&#x6f;m\" rel=\"nofollow\" shape=\"rect\">ass&#105;&#115;&#116;&#x61;&#x6e;&#x63;&#x65;&#x40;&#x6c;aur&#101;&#108;&#104;&#105;&#x6c;&#x6c;&#x2e;&#x63;&#x6f;&#x6d;<\/a>.<\/i><\/li>\n<\/ul>\n<p>SMITHS FALLS, Ontario&#8211;(BUSINESS WIRE)&#8211;Canopy Growth Corporation (\u201cCanopy Growth\u201d or the \u201cCompany\u201d) (TSX:WEED, NASDAQ:CGC) announced today that the Company has mailed (or mailed a notice of internet availability with respect to) its proxy statement and fiscal 2025 annual report to shareholders (collectively, the \u201cMeeting Materials\u201d) relating to its 2025 annual general and special meeting of shareholders (the \u201cMeeting\u201d). The Meeting is scheduled to take place on Friday, September 26, 2025 at 1:00 PM ET and will be conducted by live audio webcast at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.virtualshareholdermeeting.com%2FWEED2025&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=www.virtualshareholdermeeting.com%2FWEED2025&amp;index=2&amp;md5=00e3b4cfd9a25628f091ba8eb4ececee\" rel=\"nofollow\" shape=\"rect\">www.virtualshareholdermeeting.com\/WEED2025<\/a>.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/5\/Canopy_Growth_Corporation_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/5\/Canopy_Growth_Corporation_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/21\/Canopy_Growth_Corporation_Logo.jpg\"><\/a><\/p>\n<p>\n<b>Canopy Needs Your Vote \u2013 Vote Today and Help Us Reach Quorum<\/b><\/p>\n<p>\nEven if you plan to attend the virtual Meeting, you are encouraged to vote in advance of the Meeting and as soon as possible to ensure your vote is submitted.<\/p>\n<p>\n<b>As a requirement of the Company\u2019s NASDAQ listing, a quorum at the Meeting consists of the presence, in person, by remote communication or by proxy duly authorized, of the holders of 33 1\/3% of the outstanding shares entitled to vote at the Meeting.<\/b><\/p>\n<p>\n<b>Due to the nature of Canopy Growth\u2019s shareholder base, your presence in person (including by remote communication) or by proxy at the Meeting is critical to help the Company achieve a quorum. If quorum is not achieved, the Company will be required to adjourn the Meeting which would result in the Company incurring additional costs.<\/b><\/p>\n<p>\nShareholders of record as of the close of business on August 1, 2025 are eligible to vote at the Meeting.<\/p>\n<p>\nThe Meeting Materials have been filed on EDGAR and SEDAR+ under the Company\u2019s profile, and are available at: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.canopygrowth.com%2Finvestors%2Finvestor-events%2Fannual-general-and-special-meeting-2025&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.canopygrowth.com%2Finvestors%2Finvestor-events%2Fannual-general-and-special-meeting-2025&amp;index=3&amp;md5=25bb31d48eea61eddc49025142b9d767\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.canopygrowth.com\/investors\/investor-events\/annual-general-and-special-meeting-2025<\/a><\/p>\n<p>\nAt the Meeting, shareholders will be asked to vote on four items (each as described in the Company\u2019s proxy statement):<\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nThe election of directors;<\/li>\n<li>\nThe re-appointment of PKF O\u2019Connor Davies LLP as the Company\u2019s auditor and independent registered public accounting firm and to authorize the Company\u2019s board of directors or any responsible committee thereof to fix their remuneration;<\/li>\n<li>\nA share consolidation (also known as a reverse stock split) proposal; and<\/li>\n<li>\nAn advisory (non-binding) vote on the Company\u2019s approach to executive compensation.<\/li>\n<\/ol>\n<p>\nThe board of directors of the Company recommends shareholders vote <b><span class=\"bwuline\">FOR<\/span><\/b> each resolution.<\/p>\n<p>\n<b>How to Vote<\/b><\/p>\n<p>\nYour vote matters. Please take a moment to submit it today using one of the convenient options below.<\/p>\n<p>\nFor the majority of Canopy Growth shareholders, voting will be facilitated by Broadridge Investor Communications Corporation (\u201cBroadridge\u201d). These shareholders will receive (or be able to access) a form of proxy or voting instruction form from Broadridge with a 16-digit control number, which can be used to vote:<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwwidth50\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignc bwcellpmargin\">\n<b>Online: <\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fproxyvote.com&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=http%3A%2F%2Fproxyvote.com&amp;index=4&amp;md5=14e612911b8744a33ff978832630471c\" rel=\"nofollow\" shape=\"rect\">http:\/\/proxyvote.com<\/a><\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth50\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignc bwcellpmargin\">\n<b>By Phone: <\/b>1-800-474-7493\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nCanopy Growth shareholders who hold their shares at Interactive Brokers LLC can vote online at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fproxypush.com&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=http%3A%2F%2Fproxypush.com&amp;index=5&amp;md5=060871a1693b07afdc8e977e169d4d48\" rel=\"nofollow\" shape=\"rect\">http:\/\/proxypush.com<\/a> using the provided control number.<\/p>\n<p>\nClients of Robinhood Securities, LLC who are eligible to vote will receive a voting notice by email from <a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#x6e;&#111;&#x72;&#x65;&#112;l&#x79;&#64;r&#x6f;&#x62;&#105;&#x6e;&#x68;&#111;o&#x64;&#46;c&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x6e;&#x6f;&#x72;&#x65;&#x70;&#x6c;&#x79;&#x40;&#x72;&#x6f;&#x62;&#x69;&#x6e;&#x68;&#x6f;&#x6f;&#x64;&#x2e;&#x63;&#x6f;&#x6d;<\/a>. Voting is hosted by Say Technologies, with voting and materials available directly from the email.<\/p>\n<p>\nMany shareholders are also eligible to vote quickly and conveniently over the phone by contacting the Company\u2019s proxy solicitation agent, Laurel Hill Advisory Group (\u201cLaurel Hill\u201d), at 1\u2011877\u2011452\u20117184 (1-416-304-0211 for collect calls outside North America). Shareholders with questions about the Meeting or voting their shares can also contact Laurel Hill at the above phone numbers, or by email at <a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x61;s&#115;&#105;&#x73;&#x74;a&#110;&#x63;&#x65;&#64;&#108;&#x61;&#x75;r&#101;&#108;&#x68;&#x69;l&#108;&#x2e;&#x63;o&#109;\" rel=\"nofollow\" shape=\"rect\">&#x61;&#115;&#x73;&#105;s&#x74;&#97;n&#x63;&#101;&#x40;&#x6c;a&#x75;&#114;e&#x6c;&#104;&#x69;&#x6c;l&#x2e;&#99;o&#x6d;<\/a>.<\/p>\n<p>\n<b>Annual Report Availability<\/b><\/p>\n<p>\nInterested shareholders may also view the Company\u2019s annual report that is available at:<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.canopygrowth.com%2Fwp-content%2Fuploads%2F2025%2F08%2FCANOPY-GROWTH-CORP_AR_2025_V1.pdf&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.canopygrowth.com%2Fwp-content%2Fuploads%2F2025%2F08%2FCANOPY-GROWTH-CORP_AR_2025_V1.pdf&amp;index=6&amp;md5=1781f64eba1e0f83dba869bb4475eb8a\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.canopygrowth.com\/wp-content\/uploads\/2025\/08\/CANOPY-GROWTH-CORP_AR_2025_V1.pdf<\/a><\/p>\n<p>\n<b>About Canopy Growth<\/b><\/p>\n<p>\nCanopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.<\/p>\n<p>\nThrough an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz &amp; Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.<\/p>\n<p>\nCanopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA, LLC (\u201cCanopy USA\u201d). Canopy USA\u2019s portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi\u2011state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC (collectively, doing business as Wana), a leading North American edibles brand, and majority ownership of Lemurian, Inc.(doing business as Jetty), a California-based producer of high-quality cannabis extracts and clean vape technology.<\/p>\n<p>\nAt Canopy Growth, we\u2019re shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we\u2019re paving the way for a better understanding of all that cannabis can offer.<\/p>\n<p>\nFor more information visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.canopygrowth.com%2F&amp;esheet=54308892&amp;newsitemid=20250815204820&amp;lan=en-US&amp;anchor=www.canopygrowth.com&amp;index=7&amp;md5=8d26f34dff538cd40834786b7b375e09\" rel=\"nofollow\" shape=\"rect\">www.canopygrowth.com<\/a>. References to information included on, or accessible through, our website do not constitute incorporation by reference of the information contained at or available through our website, and you should not consider such information to be part of this press release.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlex Thomas<br \/>\n<br \/>Director, Communications<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:m&#101;&#100;&#105;&#97;&#64;&#99;&#97;&#110;&#111;&#112;&#x79;&#x67;&#x72;&#x6f;&#x77;&#x74;&#x68;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">m&#101;&#x64;&#x69;a&#64;&#99;&#x61;&#x6e;o&#112;&#121;&#x67;&#x72;o&#119;&#x74;&#x68;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<p>\nTyler Burns<br \/>\n<br \/>Director, Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x54;y&#x6c;&#101;&#x72;&#46;B&#x75;&#114;&#x6e;&#115;&#64;&#x63;a&#x6e;&#111;&#x70;&#121;g&#x72;o&#x77;&#116;&#x68;&#x2e;c&#x6f;&#109;\" rel=\"nofollow\" shape=\"rect\">&#x54;&#121;l&#x65;&#114;&#46;&#x42;&#x75;&#114;&#x6e;&#x73;&#64;c&#x61;&#110;o&#x70;&#x79;&#103;&#x72;&#x6f;&#119;t&#x68;&#46;c&#x6f;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http:\/\/proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth\u2019s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61733","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http:\/\/proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth\u2019s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-15T11:05:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now\",\"datePublished\":\"2025-08-15T11:05:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/\"},\"wordCount\":991,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815204820\\\/en\\\/2388069\\\/22\\\/Canopy_Growth_Corporation_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/\",\"name\":\"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815204820\\\/en\\\/2388069\\\/22\\\/Canopy_Growth_Corporation_Logo.jpg\",\"datePublished\":\"2025-08-15T11:05:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815204820\\\/en\\\/2388069\\\/22\\\/Canopy_Growth_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815204820\\\/en\\\/2388069\\\/22\\\/Canopy_Growth_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/","og_locale":"en_US","og_type":"article","og_title":"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Pharma Trend","og_description":"Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http:\/\/proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth\u2019s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-15T11:05:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now","datePublished":"2025-08-15T11:05:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/"},"wordCount":991,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/","url":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/","name":"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg","datePublished":"2025-08-15T11:05:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250815204820\/en\/2388069\/22\/Canopy_Growth_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/canopy-growth-announces-mailing-and-filing-of-proxy-materials-for-annual-general-and-special-meeting-and-urges-all-shareholders-to-vote-now\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61733"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61733\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}